SCHEMBL31589849

SCHEMBL31589849

CC(C)C[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.51
▸ MME P08473 4/20 0.48
▸ GNPAT O15228 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ THPO P40225 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ SLC7A5 Q01650 1/20 0.43
▸ FOLH1 Q04609 1/20 0.42
▸ ENPEP Q07075 5/20 0.42
▸ BACE1 P56817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31152880 0.96 ACE (0.48) ACEMMEGNPATKDM4EMAPT
SCHEMBL29883873 0.94 MME (0.48) ACEMMEGNPATSLC7A5ENPEP
SCHEMBL29870736 0.91 MME (0.53) MMEGNPATMAPTSLC7A5FOLH1
SCHEMBL21828594 0.91 ACE (0.61) ACEMMEKDM4EMAPTTHRB
SCHEMBL21828595 0.91 ACE (0.61) ACEMMEKDM4EMAPTTHRB
SCHEMBL29630563 0.90 MME (0.51) MMEGNPATMAPTSLC7A5FOLH1
SCHEMBL29414957 0.90 MME (0.51) MMEGNPATMAPTSLC7A5FOLH1
SCHEMBL30311049 0.90 ACE (0.56) ACEMMEKDM4EMAPTTHRB
SCHEMBL30288000 0.90 ACE (0.56) ACEMMEKDM4EMAPTTHRB
SCHEMBL24728981 0.90 ACE (0.50) ACEMMEGNPATKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120037261-A Targeting therapeutic pharmaceutical composition based on coupling of immune cells and small molecular peptides 北京钦川科技有限公司 2025-05-27 — — CN claimed
CN-120037261-A Targeting therapeutic pharmaceutical composition based on coupling of immune cells and small molecular peptides 北京钦川科技有限公司 2025-05-27 — — CN disclosed
Send feedback